Oramed

Breakthrough medical technology

Demand for alternative insulin delivery technologies is rising.
Type 2 diabetes therapy market is expected to exceed US $15.3 billion in 2013.
Oramed's team of scientists is among one of the most experienced groups in the world in the research and development of oral insulin.
Effectiveness of insulin capsule is already proven successful on trials on animals at Hadassah University Hospital in Jerusalem.
Oral insulin capsule enable the delivery of insulin in a more physiological manner than by injection